Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Brain Behav Immun ; 120: 248-255, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38795783

RÉSUMÉ

Major depressive disorder (MDD) is associated with Alzheimer's disease (AD) but the precise mechanisms underlying this relationship are not understood. While it is well established that cerebrospinal fluid (CSF) soluble levels of triggering receptor expressed on myeloid cells 2 (sTREM2) increase during early stages of AD, how sTREM2 levels behave in subjects with MDD is not known. In a longitudinal study, we measured CSF sTREM2 levels in 27 elderly cognitively intact individuals with late-life major depression (LLMD) and in 19 healthy controls. We tested the hypothesis that, similarly to what happens in early stages of AD, CSF sTREM2 would be elevated in MDD. In addition, we compared the associations of CSF sTREM2, pro- and anti- inflammatory, and AD biomarkers in LLMD and control subjects. Surprisingly, we found that mean CSF sTREM2 levels were significantly reduced in LLMD compared to controls. This reduction was no longer significant at the 3-year follow-up visit when depression severity improved. In addition, we found that CSF sTREM2 was associated with AD biomarkers and proinflammatory cytokines in controls but not in LLMD. These findings suggest that impaired microglia phagocytic response to AD pathology may be a novel link between MDD and AD.


Sujet(s)
Maladie d'Alzheimer , Marqueurs biologiques , Trouble dépressif majeur , Glycoprotéines membranaires , Microglie , Récepteurs immunologiques , Humains , Trouble dépressif majeur/métabolisme , Trouble dépressif majeur/liquide cérébrospinal , Mâle , Microglie/métabolisme , Femelle , Sujet âgé , Récepteurs immunologiques/métabolisme , Glycoprotéines membranaires/liquide cérébrospinal , Glycoprotéines membranaires/métabolisme , Maladie d'Alzheimer/liquide cérébrospinal , Maladie d'Alzheimer/métabolisme , Marqueurs biologiques/liquide cérébrospinal , Études longitudinales , Phagocytose/physiologie , Cytokines/métabolisme , Cytokines/liquide cérébrospinal , Adulte d'âge moyen , Sujet âgé de 80 ans ou plus , Inflammation/métabolisme , Inflammation/liquide cérébrospinal
2.
Front Behav Neurosci ; 16: 958609, 2022.
Article de Anglais | MEDLINE | ID: mdl-36187377

RÉSUMÉ

Humans have a remarkably high capacity and long duration memory for complex scenes. Previous research documents the neural substrates that allow for efficient categorization of scenes from other complex stimuli like objects and faces, but the spatiotemporal neural dynamics underlying scene memory at timescales relevant to working and longer-term memory are less well understood. In the present study, we used high density EEG during a visual continuous recognition task in which new, old, and scrambled scenes consisting of color outdoor photographs were presented at an average rate 0.26 Hz. Old scenes were single repeated presentations occurring within either a short-term (< 20 s) or longer-term intervals of between 30 s and 3 min or 4 and 10 min. Overall recognition was far above chance, with better performance at shorter- than longer-term intervals. Sensor-level ANOVA and post hoc pairwise comparisons of event related potentials (ERPs) revealed three main findings: (1) occipital and parietal amplitudes distinguishing new and old from scrambled scenes; (2) frontal amplitudes distinguishing old from new scenes with a central positivity highest for hits compared to misses, false alarms and correct rejections; and (3) frontal and parietal changes from ∼300 to ∼600 ms distinguishing among old scenes previously encountered at short- and longer-term retention intervals. These findings reveal how distributed spatiotemporal neural changes evolve to support short- and longer-term recognition of complex scenes.

3.
Int J Neurosci ; 131(4): 357-361, 2021 Apr.
Article de Anglais | MEDLINE | ID: mdl-32228205

RÉSUMÉ

Purpose/aim of the study: Major depressive disorder (MDD) in late life is linked to increased risk of subsequent dementia, but it is still unclear exactly what pathophysiological mechanisms underpin this link. A potential mechanism related to elevated risk of dementia in MDD is increased levels of α-synuclein (α-Syn), a protein found in presynaptic neuronal terminals.Materials and methods: In this study, we examined cerebrospinal fluid (CSF) levels of α-Syn in conjunction with biomarkers of neurodegeneration (amyloid-ß 42, total and phospho tau) and synaptic dysfunction (neurogranin), and measures of memory ability, in 27 cognitively intact older individuals with MDD and 19 controls.Results: Our results show that CSF α-Syn levels did not significantly differ across depressed and control participants, but α-Syn was directly associated with neurogranin levels, and indirectly linked to poorer memory ability.Conclusions: All in all, we found that α-Syn may be implicated in the association between late life MDD and synaptic dysfunction, although further research is needed to confirm these results.


Sujet(s)
Trouble dépressif majeur/liquide cérébrospinal , Neurogranine/liquide cérébrospinal , alpha-Synucléine/liquide cérébrospinal , Sujet âgé , Trouble dépressif majeur/psychologie , Femelle , Humains , Mâle , Adulte d'âge moyen
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE